Bionor Pharma ASA | Income Statement
Fiscal year is January-December. All values NOK Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,200.00
1,766.00
85.00
691,497.00
883,036.00
924,053
Unusual Expense
-
-
-
21,956.00
-
-
Pretax Income
85,434.00
68,054.00
96,726.00
38,338.00
95,131.00
177,628
Consolidated Net Income
85,434.00
68,054.00
96,726.00
28,403.00
74,078.00
133,868
Net Income
85,434.00
68,054.00
96,726.00
23,547.00
69,737.00
136,624
Net Income After Extraordinaries
85,434.00
68,054.00
96,726.00
24,767.00
206,196.00
136,624
Net Income Available to Common
85,434.00
68,054.00
96,726.00
22,327.00
66,722.00
136,624
EPS (Basic)
38.36
26.49
35.62
0.60
1.38
2.46
Basic Shares Outstanding
2,253.60
2,551.20
2,724.20
33,944.90
48,443.70
55,491
EPS (Diluted)
37.91
26.68
35.51
0.66
1.38
2.46
Diluted Shares Outstanding
2,253.60
2,551.20
2,724.20
33,944.90
48,443.70
55,491
Minority Interest Expense
-
-
-
4,856.00
4,341.00
2,756
Total Expense
-
-
-
632,933.00
786,537.00
748,905
Operating Income
-
-
-
58,564.00
96,499.00
175,148
Income Taxes
-
-
-
9,935.00
21,053.00
43,760
Non-Operating Income (Expense)
2,461.00
1,596.00
761.00
1,730.00
1,368.00
2,480
About Bionor Pharma ASA
View Profile
